[{"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-001", "question": "A 34-year-old woman at 32 weeks gestation presents with hemodynamic instability after sudden right upper quadrant pain. CT angiography demonstrates rupture of a 12 cm hepatic hemangioma with active extravasation and consumptive coagulopathy (platelets 45,000, INR 2.3). What is the definitive management strategy that optimizes maternal-fetal survival?", "options": ["A) Emergency cesarean section followed by immediate right hepatectomy", "B) Immediate exploratory laparotomy with hepatic artery ligation and packing", "C) Hepatic artery embolization with gelatin sponge, delayed cesarean section at 34 weeks", "D) Emergent cesarean section with concurrent hepatic artery embolization in hybrid OR", "E) Staged approach: hepatic artery embolization first, then cesarean section once coagulopathy corrects"], "answer": "E", "answer_index": 4, "explanation": "In third-trimester ruptured giant hepatic hemangioma with Kasabach-Merritt phenomenon, staged management with hepatic artery embolization first to control bleeding and reverse coagulopathy, followed by semi-elective cesarean section, yields superior maternal-fetal outcomes compared to simultaneous or surgery-first approaches. Embolization with gelatin sponge preserves future liver function while controlling hemorrhage.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – option E is not the best answer given the stem.\\nKey stem clues: 32 weeks gestation, hemodynamic instability, CT shows active extravasation from a ruptured 12‑cm hepatic hemangioma, consumptive coagulopathy (platelets 45k, INR 2.3). The question asks for definitive management that optimizes maternal–fetal survival in an unstable patient with ongoing intraperitoneal hemorrhage.\\nAnalysis: In the setting of hemodynamic instability and active extravasation, delaying definitive hemorrhage control for a “staged” approach (E) is unsafe; embolization “first, then cesarean once coagulopathy corrects” implies non-emergent pacing despite shock, and standard care favors immediate control of hemorrhage and delivery if the fetus is viable. A more defensible best answer among the available options is D: emergent cesarean section with concurrent hepatic artery embolization in a hybrid OR, which provides rapid maternal resuscitation, definitive bleeding control, and prompt delivery at 32 weeks. Options A–C are less suitable: A involves major hepatic resection in a coagulopathic, unstable pregnant patient; B omits embolization and is temporizing; C delays intervention despite instability. Thus the keyed answer conflicts with accepted emergency management principles.\\nMinimal fix: Change the keyed correct answer to D and adjust the rationale accordingly to emphasize simultaneous delivery and embolization in a hybrid OR.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – option E is not the best answer given the stem.\nKey stem clues: 32 weeks gestation, hemodynamic instability, CT shows active extravasation from a ruptured 12‑cm hepatic hemangioma, consumptive coagulopathy (platelets 45k, INR 2.3). The question asks for definitive management that optimizes maternal–fetal survival in an unstable patient with ongoing intraperitoneal hemorrhage.\nAnalysis: In the setting of hemodynamic instability and active extravasation, delaying definitive hemorrhage control for a “staged” approach (E) is unsafe; embolization “first, then cesarean once coagulopathy corrects” implies non-emergent pacing despite shock, and standard care favors immediate control of hemorrhage and delivery if the fetus is viable. A more defensible best answer among the available options is D: emergent cesarean section with concurrent hepatic artery embolization in a hybrid OR, which provides rapid maternal resuscitation, definitive bleeding control, and prompt delivery at 32 weeks. Options A–C are less suitable: A involves major hepatic resection in a coagulopathic, unstable pregnant patient; B omits embolization and is temporizing; C delays intervention despite instability. Thus the keyed answer conflicts with accepted emergency management principles.\nMinimal fix: Change the keyed correct answer to D and adjust the rationale accordingly to emphasize simultaneous delivery and embolization in a hybrid OR.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-002", "question": "A 68-year-old man with end colostomy presents with a 6 cm parastomal hernia and 8 cm prolapse through the fascial defect. He has failed conservative management with hernia belt. What is the optimal surgical repair technique and mesh configuration?", "options": ["A) Laparoscopic keyhole repair with heavyweight polypropylene mesh", "B) Open Sugarbaker repair with lightweight macroporous polypropylene mesh", "C) Laparoscopic modified Sugarbaker with dual-layer composite mesh (ePTFE/polypropylene)", "D) Open keyhole repair with biologic mesh (porcine dermis)", "E) Laparoscopic sandwich repair with two lightweight polypropylene meshes"], "answer": "B", "answer_index": 1, "explanation": "For parastomal hernia with significant prolapse, open Sugarbaker repair with lightweight macroporous polypropylene mesh provides superior recurrence prevention while allowing parastomal bowel mobility. The Sugarbaker configuration prevents mesh erosion by avoiding circumferential stoma encirclement, and lightweight mesh reduces infection risk in contaminated fields compared to composite or biologic meshes.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N\\nVerdict on keyed answer: No defensible answer as written\\nKey stem clues: 68-year-old man, end colostomy, 6 cm parastomal hernia, 8 cm prolapse, failed conservative management, question asks for “optimal surgical repair technique and mesh configuration.” No additional details on prior laparotomy, adhesions, BMI, comorbidities, or degree of contamination are provided.\\nThe explanation states that open Sugarbaker with lightweight macroporous polypropylene is preferred because the Sugarbaker configuration avoids circumferential encirclement and lightweight mesh reduces infection risk vs composite or biologic meshes. However, this rationale is problematic: in a stoma field (clean-contaminated), many surgeons favor intraperitoneal onlay composite mesh over bare polypropylene due to adhesion and fistula risk; biologic mesh is not clearly inferior in infection risk compared to synthetic in current data. Laparoscopic modified Sugarbaker with composite mesh (C) is widely accepted and often preferred when feasible. The item declares open Sugarbaker with pure polypropylene as clearly “optimal” without sufficient clinical context, making B not uniquely or clearly best.\\nMinimal fix: Specify that the patient has dense adhesions precluding laparoscopy and that current institutional protocol favors open Sugarbaker with lightweight polypropylene, or re-key to C and adjust rationale to align with contemporary evidence on composite meshes.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N\nVerdict on keyed answer: No defensible answer as written\nKey stem clues: 68-year-old man, end colostomy, 6 cm parastomal hernia, 8 cm prolapse, failed conservative management, question asks for “optimal surgical repair technique and mesh configuration.” No additional details on prior laparotomy, adhesions, BMI, comorbidities, or degree of contamination are provided.\nThe explanation states that open Sugarbaker with lightweight macroporous polypropylene is preferred because the Sugarbaker configuration avoids circumferential encirclement and lightweight mesh reduces infection risk vs composite or biologic meshes. However, this rationale is problematic: in a stoma field (clean-contaminated), many surgeons favor intraperitoneal onlay composite mesh over bare polypropylene due to adhesion and fistula risk; biologic mesh is not clearly inferior in infection risk compared to synthetic in current data. Laparoscopic modified Sugarbaker with composite mesh (C) is widely accepted and often preferred when feasible. The item declares open Sugarbaker with pure polypropylene as clearly “optimal” without sufficient clinical context, making B not uniquely or clearly best.\nMinimal fix: Specify that the patient has dense adhesions precluding laparoscopy and that current institutional protocol favors open Sugarbaker with lightweight polypropylene, or re-key to C and adjust rationale to align with contemporary evidence on composite meshes.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-003", "question": "A 3-year-old child with bilateral retinoblastoma has persistent class 3 vitreous seeds (vitreous clouds) in the right eye after six cycles of systemic chemotherapy and three intravitreal melphalan injections (30 µg). Examination shows tumor regression but diffuse non-confluent vitreous opacities. What is the next definitive management step?", "options": ["A) Increase intravitreal melphalan dose to 50 µg weekly for three doses", "B) Plaque brachytherapy with 125I to deliver 40 Gy to vitreous base", "C) Enucleation with histopathologic risk factor assessment", "D) Intravitreal topotecan 20 µg alternating with melphalan every 2 weeks", "E) External beam radiation therapy 45 Gy to entire globe"], "answer": "D", "answer_index": 3, "explanation": "For persistent class 3 vitreous seeds after standard melphalan, alternating intravitreal topotecan with melphalan provides synergistic tumoricidal activity while avoiding retinal toxicity from dose escalation. This protocol achieves 85% globe salvage for refractory seeds compared to 40% with continued melphalan alone, and avoids the late effects of external beam radiation in hereditary retinoblastoma.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 3-year-old with bilateral retinoblastoma (heritable form), persistent class 3 vitreous seeds after six cycles of systemic chemotherapy and three standard-dose intravitreal melphalan (30 µg); tumor itself has regressed; residual disease is diffuse, non-confluent vitreous opacities (seeds); question asks for next definitive management step.\\n\\nMost likely management concept: salvage of a functionally and cosmetically useful globe in hereditary retinoblastoma while minimizing retinal toxicity and avoiding external beam radiation late effects. After melphalan-refractory vitreous seeds, adding/alternating intravitreal topotecan is evidence-based and commonly used.\\n\\nChoice D fits this best: intravitreal topotecan 20 µg alternating with melphalan every 2 weeks is a recognized salvage protocol for refractory vitreous seeds, with high globe salvage and acceptable toxicity.\\n\\nOther options: A (melphalan dose escalation to 50 µg) risks significant retinal toxicity and is not standard; B plaque brachytherapy is directed to focal tumors, not diffuse vitreous seeds; C enucleation is premature with chemosensitive disease and bilateral involvement; E external beam RT is avoided in hereditary cases because of secondary malignancy and growth effects.\\n\\nMinimal fix: Specify visual potential or absence of other high-risk features to reinforce globe-salvage intent and make D even more unambiguous.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 3-year-old with bilateral retinoblastoma (heritable form), persistent class 3 vitreous seeds after six cycles of systemic chemotherapy and three standard-dose intravitreal melphalan (30 µg); tumor itself has regressed; residual disease is diffuse, non-confluent vitreous opacities (seeds); question asks for next definitive management step.\n\nMost likely management concept: salvage of a functionally and cosmetically useful globe in hereditary retinoblastoma while minimizing retinal toxicity and avoiding external beam radiation late effects. After melphalan-refractory vitreous seeds, adding/alternating intravitreal topotecan is evidence-based and commonly used.\n\nChoice D fits this best: intravitreal topotecan 20 µg alternating with melphalan every 2 weeks is a recognized salvage protocol for refractory vitreous seeds, with high globe salvage and acceptable toxicity.\n\nOther options: A (melphalan dose escalation to 50 µg) risks significant retinal toxicity and is not standard; B plaque brachytherapy is directed to focal tumors, not diffuse vitreous seeds; C enucleation is premature with chemosensitive disease and bilateral involvement; E external beam RT is avoided in hereditary cases because of secondary malignancy and growth effects.\n\nMinimal fix: Specify visual potential or absence of other high-risk features to reinforce globe-salvage intent and make D even more unambiguous.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-004", "question": "A 45-year-old recreational athlete presents 8 weeks after feeling a 'pop' in his knee. Examination reveals a chronic patellar tendon rupture with 7 cm retraction gap and inability to perform straight leg raise. MRI shows tendon degeneration but intact retinaculum. What is the optimal reconstruction technique?", "options": ["A) Primary repair with Krackow sutures and wire augmentation", "B) Ipsilateral hamstring autograft reconstruction through bone tunnels", "C) Contralateral bone-patellar tendon-bone autograft with interference screws", "D) Achilles tendon allograft with patellar bone block fixation", "E) Staged reconstruction: tendon lengthening first, then primary repair"], "answer": "C", "answer_index": 2, "explanation": "For chronic patellar tendon rupture with >6 cm gap, contralateral bone-patellar tendon-bone autograft provides optimal biomechanical strength and facilitates early mobilization. The graft's bone blocks allow secure interference screw fixation in patellar and tibial tunnels, restoring native tendon length and avoiding the quadriceps lag associated with hamstring or allograft reconstructions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple defensible) / possibly U.\\nVerdict on keyed answer: Not uniquely determinable; C is defensible but D is also strongly defensible as “optimal.”\\n\\nKey stem clues: 45-year-old, chronic patellar tendon rupture, 8 weeks post-injury, 7 cm retraction gap (>6 cm), degenerative tendon, intact retinaculum. Question asks for “optimal reconstruction technique,” not autograft vs allograft preference, and gives no constraints about donor-site morbidity, activity level beyond “recreational athlete,” or graft availability.\\n\\nBiomechanically, both contralateral BPTB autograft (C) and Achilles tendon allograft with patellar bone block (D) are well-accepted options for chronic patellar tendon ruptures with large gaps. Literature and practice patterns vary; many surgeons favor Achilles allograft for sizeable defects to avoid contralateral extensor mechanism morbidity. The stem doesn’t provide a discriminating clinical factor that clearly favors contralateral BPTB over Achilles allograft.\\n\\nOther options (A, B, E) are reasonably excluded: primary repair not feasible with 7 cm gap; hamstring autograft often insufficient for this size defect; staged lengthening not standard first-line in this setting.\\n\\nMinimal fix: Either (1) specify a preference for autograft over allograft (e.g., “he strongly wishes to avoid allograft tissue” or “institution lacks allografts”), or (2) remove D, or (3) change key/explanation to acknowledge both and specify why one is preferred.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple defensible) / possibly U.\nVerdict on keyed answer: Not uniquely determinable; C is defensible but D is also strongly defensible as “optimal.”\n\nKey stem clues: 45-year-old, chronic patellar tendon rupture, 8 weeks post-injury, 7 cm retraction gap (>6 cm), degenerative tendon, intact retinaculum. Question asks for “optimal reconstruction technique,” not autograft vs allograft preference, and gives no constraints about donor-site morbidity, activity level beyond “recreational athlete,” or graft availability.\n\nBiomechanically, both contralateral BPTB autograft (C) and Achilles tendon allograft with patellar bone block (D) are well-accepted options for chronic patellar tendon ruptures with large gaps. Literature and practice patterns vary; many surgeons favor Achilles allograft for sizeable defects to avoid contralateral extensor mechanism morbidity. The stem doesn’t provide a discriminating clinical factor that clearly favors contralateral BPTB over Achilles allograft.\n\nOther options (A, B, E) are reasonably excluded: primary repair not feasible with 7 cm gap; hamstring autograft often insufficient for this size defect; staged lengthening not standard first-line in this setting.\n\nMinimal fix: Either (1) specify a preference for autograft over allograft (e.g., “he strongly wishes to avoid allograft tissue” or “institution lacks allografts”), or (2) remove D, or (3) change key/explanation to acknowledge both and specify why one is preferred.\n", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-005", "question": "A 28-year-old man presents 6 hours after penile trauma during intercourse. Examination reveals swelling, deformity, and blood at the meatus. Retrograde urethrogram shows extravasation at the bulbar urethra without contrast reaching the bladder. What is the definitive surgical management?", "options": ["A) Immediate exploration via circumferential subcoronal incision with primary urethral anastomosis", "B) Delayed reconstruction after 3 months with buccal mucosa graft urethroplasty", "C) Suprapubic catheter placement with conservative management", "D) Immediate exploration with urethral repair over catheter without anastomosis", "E) Endoscopic urethral realignment with catheter stenting"], "answer": "D", "answer_index": 3, "explanation": "Penile fracture with concomitant partial urethral injury requires immediate exploration via circumferential degloving incision. Most urethral injuries are partial disruptions that can be repaired primarily over a catheter without tension-free anastomosis, preserving urethral length. Formal graft urethroplasty is reserved for complete transections or delayed presentations, while endoscopic management misses associated corporal injuries.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (no answer defensible)\\nVerdict on keyed answer: No defensible answer as written\\nKey stem clues: 28-year-old man, penile trauma during intercourse, swelling/deformity (penile fracture picture), blood at meatus, retrograde urethrogram with extravasation at bulbar urethra and no contrast into bladder. This defines an anterior (bulbar) urethral injury; the stem does not clearly state corporal rupture or partial vs complete urethral disruption.\\nMain logical issues: The explanation assumes a penile fracture with a partial urethral injury, but this is not established in the stem. The RUG pattern (extravasation with no contrast into bladder) is more consistent with complete disruption of the bulbar urethra, for which immediate repair over catheter without anastomosis (D) is not standard. In that interpretation, delayed urethroplasty (B) or suprapubic diversion initially (C) become defensible, so no single best option is clearly supported. Thus the keyed answer cannot be uniquely justified.\\nMain medical accuracy issues: Management of isolated bulbar urethral injury vs penile fracture-associated injury is conflated; the RUG description does not match the teaching point.\\nMinimal fix: Explicitly state penile fracture with partial bulbar urethral tear and intact continuity on RUG, so immediate primary repair over catheter is clearly indicated and matches D.\\n\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (no answer defensible)\nVerdict on keyed answer: No defensible answer as written\nKey stem clues: 28-year-old man, penile trauma during intercourse, swelling/deformity (penile fracture picture), blood at meatus, retrograde urethrogram with extravasation at bulbar urethra and no contrast into bladder. This defines an anterior (bulbar) urethral injury; the stem does not clearly state corporal rupture or partial vs complete urethral disruption.\nMain logical issues: The explanation assumes a penile fracture with a partial urethral injury, but this is not established in the stem. The RUG pattern (extravasation with no contrast into bladder) is more consistent with complete disruption of the bulbar urethra, for which immediate repair over catheter without anastomosis (D) is not standard. In that interpretation, delayed urethroplasty (B) or suprapubic diversion initially (C) become defensible, so no single best option is clearly supported. Thus the keyed answer cannot be uniquely justified.\nMain medical accuracy issues: Management of isolated bulbar urethral injury vs penile fracture-associated injury is conflated; the RUG description does not match the teaching point.\nMinimal fix: Explicitly state penile fracture with partial bulbar urethral tear and intact continuity on RUG, so immediate primary repair over catheter is clearly indicated and matches D.\n", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-006", "question": "A 52-year-old woman develops clear rhinorrhea 3 days after endoscopic sinus surgery for revision frontal sinusitis. Intraoperative findings showed a 3 mm defect in the posterior table of the right frontal sinus. What is the optimal reconstruction method?", "options": ["A) Nasoseptal flap pedicled on posterior septal artery", "B) Middle turbinate flap with preservation of conchal crest attachment", "C) Free mucosal graft from inferior turbinate with tissue sealant", "D) Fat graft plugging with fascia lata overlay", "E) Synthetic dural substitute with fibrin glue"], "answer": "B", "answer_index": 1, "explanation": "For posterior table frontal sinus defects, the middle turbinate flap provides superior reach and vascularity compared to nasoseptal flaps. Preserving the conchal crest attachment maintains the axial blood supply from the sphenopalatine artery, ensuring graft survival in the poorly vascularized frontal sinus. Free grafts and synthetic materials have high failure rates in this location due to gravitational stress and limited recipient bed vascularity.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 52-year-old woman; postoperative clear rhinorrhea 3 days after endoscopic sinus surgery; known 3 mm posterior table frontal sinus defect; question asks for optimal reconstruction method. This implies a small anterior skull base CSF leak at the posterior frontal sinus table, a difficult-to-access, relatively avascular region where a vascularized flap is preferred.\\nThe keyed answer (B, middle turbinate flap with preserved conchal crest attachment) is consistent with contemporary endoscopic skull base practice: the pedicled middle turbinate flap can reliably reach the frontal recess/posterior table, retains sphenopalatine-based vascularity, and is sized appropriately for a 3 mm defect. Option A (nasoseptal flap) is technically possible but has inferior reach and angle in frontal sinus, especially for isolated small posterior table defects; it is more commonly used for larger central skull base defects. Options C and E are free/synthetic materials without vascularity—less ideal in this poorly vascularized, gravity-dependent location. Option D (fat + fascia) is more typical for larger defects or open approaches.\\nNo major medical inaccuracies are evident; the explanation’s emphasis on flap vascularity and frontal sinus challenges is appropriate.\\nMinimal fix: Explicitly state this is an endoscopic repair of a small posterior table CSF leak in the frontal sinus to reinforce the context.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 52-year-old woman; postoperative clear rhinorrhea 3 days after endoscopic sinus surgery; known 3 mm posterior table frontal sinus defect; question asks for optimal reconstruction method. This implies a small anterior skull base CSF leak at the posterior frontal sinus table, a difficult-to-access, relatively avascular region where a vascularized flap is preferred.\nThe keyed answer (B, middle turbinate flap with preserved conchal crest attachment) is consistent with contemporary endoscopic skull base practice: the pedicled middle turbinate flap can reliably reach the frontal recess/posterior table, retains sphenopalatine-based vascularity, and is sized appropriately for a 3 mm defect. Option A (nasoseptal flap) is technically possible but has inferior reach and angle in frontal sinus, especially for isolated small posterior table defects; it is more commonly used for larger central skull base defects. Options C and E are free/synthetic materials without vascularity—less ideal in this poorly vascularized, gravity-dependent location. Option D (fat + fascia) is more typical for larger defects or open approaches.\nNo major medical inaccuracies are evident; the explanation’s emphasis on flap vascularity and frontal sinus challenges is appropriate.\nMinimal fix: Explicitly state this is an endoscopic repair of a small posterior table CSF leak in the frontal sinus to reinforce the context.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-007", "question": "A 62-year-old man with left hemiplegia 4 months post-stroke has severe shoulder pain and 2 cm inferior subluxation on exam. EMG shows spastic co-contraction of posterior deltoid and supraspinatus without voluntary motor unit recruitment. What is the optimal botulinum toxin injection protocol?", "options": ["A) 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus", "B) 200 units onabotulinumtoxinA injected into subscapularis and pectoralis major only", "C) 50 units abobotulinumtoxinA into supraspinatus with ultrasound guidance", "D) 150 units incobotulinumtoxinA into posterior deltoid, supraspinatus, and upper trapezius", "E) 75 units onabotulinumtoxinA into posterior deltoid only"], "answer": "A", "answer_index": 0, "explanation": "For spasticity-driven post-stroke shoulder pain with subluxation, EMG-guided injection of 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus reduces painful co-contraction while preserving anterior deltoid function for shoulder flexion. Targeting only internal rotators (subscapularis/pectoralis) worsens subluxation, and higher doses cause excessive weakness. The 1:1 conversion ratio of incobotulinumtoxinA provides predictable effect duration.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 62-year-old, 4 months post-stroke, left hemiplegia, severe shoulder pain, 2 cm inferior subluxation, EMG with spastic co-contraction of posterior deltoid and supraspinatus, no voluntary motor unit recruitment. This indicates painful spasticity in muscles that normally help support the humeral head, with concern for worsening subluxation if over- or mis-treated.\\nOption A targets exactly the overactive supporting muscles (posterior deltoid, supraspinatus) with a moderate total dose (100 U incobotulinumtoxinA) consistent with common dosing ranges and preserves anterior deltoid/other stabilizers, aligning with the explanation. B targets internal rotators only and would not address the identified co-contraction and could increase subluxation; C uses wrong toxin and very low dose; D uses higher total dose and adds upper trapezius, risking more weakness and not clearly indicated from EMG; E treats only posterior deltoid and under-treats supraspinatus.\\nNo internal contradictions or clear alternative best choice; the key matches the best-supported protocol based on the stem.\\nMain medical accuracy issue: minor—exact dosing regimens vary and are not strictly evidence-based, but the general pattern is reasonable.\\nMinimal fix: Add explicit statement that EMG confirmed spastic overactivity of posterior deltoid and supraspinatus as primary contributors to pain and subluxation, and that anterior deltoid remains functional, to better justify the chosen targets and dose.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 62-year-old, 4 months post-stroke, left hemiplegia, severe shoulder pain, 2 cm inferior subluxation, EMG with spastic co-contraction of posterior deltoid and supraspinatus, no voluntary motor unit recruitment. This indicates painful spasticity in muscles that normally help support the humeral head, with concern for worsening subluxation if over- or mis-treated.\nOption A targets exactly the overactive supporting muscles (posterior deltoid, supraspinatus) with a moderate total dose (100 U incobotulinumtoxinA) consistent with common dosing ranges and preserves anterior deltoid/other stabilizers, aligning with the explanation. B targets internal rotators only and would not address the identified co-contraction and could increase subluxation; C uses wrong toxin and very low dose; D uses higher total dose and adds upper trapezius, risking more weakness and not clearly indicated from EMG; E treats only posterior deltoid and under-treats supraspinatus.\nNo internal contradictions or clear alternative best choice; the key matches the best-supported protocol based on the stem.\nMain medical accuracy issue: minor—exact dosing regimens vary and are not strictly evidence-based, but the general pattern is reasonable.\nMinimal fix: Add explicit statement that EMG confirmed spastic overactivity of posterior deltoid and supraspinatus as primary contributors to pain and subluxation, and that anterior deltoid remains functional, to better justify the chosen targets and dose.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-008", "question": "A 71-year-old man with history of scalp radiation for basal cell carcinoma 20 years ago develops a 5 cm recurrent tumor with 2 cm calvarial erosion. After oncologic resection, there is a full-thickness calvarial defect with dural exposure. What is the optimal reconstruction?", "options": ["A) Latissimus dorsi myocutaneous free flap with split-thickness skin graft", "B) Omental free flap with vascularized bone graft", "C) Pericranial flap rotation with split calvarial graft", "D) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty", "E) Anterolateral thigh fasciocutaneous flap with titanium mesh"], "answer": "D", "answer_index": 3, "explanation": "In irradiated scalp defects with calvarial exposure, muscle-only free flaps (latissimus dorsi) provide robust vascularity to compromised beds while allowing secondary skin grafting. The muscle conforms better to calvarial contours than fasciocutaneous flaps, and delayed cranioplasty after soft tissue healing reduces hardware exposure risk. Myocutaneous flaps are too bulky, and local pericranial flaps have unreliable vascularity in previously irradiated fields.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 71-year-old, prior scalp radiation, large 5 cm recurrent tumor, 2 cm calvarial erosion, full-thickness calvarial defect with dural exposure after resection. These features imply an irradiated, compromised scalp with bone loss and exposed dura, requiring robust vascularized soft-tissue coverage and cautious timing of rigid reconstruction.\\nThe most appropriate strategy is a muscle-only free flap (latissimus dorsi) with skin graft and delayed cranioplasty (D): muscle offers excellent vascularity in irradiated beds, conforms to irregular calvarial/dural contours, and staged cranioplasty reduces risk of hardware exposure/infection.\\nOption A (latissimus myocutaneous) is often too bulky in scalp, especially in elderly, and immediate bulk is undesirable here per common teaching. B (omental + vascularized bone) is highly unusual for this indication and overly complex. C (pericranial rotation plus split calvarial graft) is unreliable in irradiated fields and harvest of split calvarium is problematic with prior radiation and current defect. E (ALT fasciocutaneous with titanium mesh) risks poor take and mesh exposure in irradiated, contaminated bed.\\nMain medical issue: minor—some surgeons may use fasciocutaneous flaps, but muscle-first with delayed cranioplasty is well-supported.\\nMinimal fix: Explicitly state “heavily irradiated scalp and calvarium” to emphasize need for robust vascularized soft tissue and staged cranioplasty.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 71-year-old, prior scalp radiation, large 5 cm recurrent tumor, 2 cm calvarial erosion, full-thickness calvarial defect with dural exposure after resection. These features imply an irradiated, compromised scalp with bone loss and exposed dura, requiring robust vascularized soft-tissue coverage and cautious timing of rigid reconstruction.\nThe most appropriate strategy is a muscle-only free flap (latissimus dorsi) with skin graft and delayed cranioplasty (D): muscle offers excellent vascularity in irradiated beds, conforms to irregular calvarial/dural contours, and staged cranioplasty reduces risk of hardware exposure/infection.\nOption A (latissimus myocutaneous) is often too bulky in scalp, especially in elderly, and immediate bulk is undesirable here per common teaching. B (omental + vascularized bone) is highly unusual for this indication and overly complex. C (pericranial rotation plus split calvarial graft) is unreliable in irradiated fields and harvest of split calvarium is problematic with prior radiation and current defect. E (ALT fasciocutaneous with titanium mesh) risks poor take and mesh exposure in irradiated, contaminated bed.\nMain medical issue: minor—some surgeons may use fasciocutaneous flaps, but muscle-first with delayed cranioplasty is well-supported.\nMinimal fix: Explicitly state “heavily irradiated scalp and calvarium” to emphasize need for robust vascularized soft tissue and staged cranioplasty.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-009", "question": "A 28-year-old woman presents with progressive myelopathy over 6 months. MRI shows a holocord enhancing lesion from C2 to T9 with cystic components. Intraoperative neuromonitoring shows 60% amplitude reduction in motor evoked potentials after initial tumor debulking. What is the next surgical decision?", "options": ["A) Continue aggressive debulking despite signal changes", "B) Halt resection, perform duraplasty, and plan staged resection", "C) Switch to ultrasonic aspiration for gentler tumor removal", "D) Administer high-dose steroids and continue resection", "E) Perform en bloc resection of involved cord segments"], "answer": "B", "answer_index": 1, "explanation": "For holocord ependymoma, intraoperative neuromonitoring with >50% MEP amplitude reduction mandates immediate cessation of resection to prevent permanent neurologic deficit. Staged resection after allowing neural recovery (typically 3-6 months) achieves maximal safe cytoreduction. Continuing despite signal loss causes paraplegia, while en bloc resection is contraindicated in holocord lesions. Ultrasonic aspiration still transmits vibratory injury to compressed neural tissue.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 28-year-old woman with progressive myelopathy, holocord enhancing intramedullary lesion C2–T9 (consistent with extensive intramedullary tumor such as ependymoma), intraoperative neuromonitoring shows 60% reduction in MEP amplitude after initial debulking. A >50% drop in MEPs is widely used as a threshold indicating high risk of permanent motor deficit, prompting cessation or backing off the resection to prioritize neurologic safety.\\n\\nOption B (halt resection, duraplasty, staged approach) aligns with the principle of maximal safe resection guided by neuromonitoring and is the only clearly appropriate immediate surgical decision. A and D advocate continuing despite a major MEP drop, which is unsafe and contrary to intraoperative neuromonitoring standards. C changes the tool but not the decision to continue, ignoring the warning sign. E (en bloc resection of involved segments) is not appropriate for a holocord intramedullary lesion and would be devastating neurologically.\\n\\nMain medical accuracy issues: Minor—specific 3–6 month interval for staged resection is somewhat dogmatic but not harmful. Minimal fix: Clarify in the explanation that resection is halted immediately upon significant MEP decline and that any further resection is reconsidered only after neurologic and radiologic reassessment.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 28-year-old woman with progressive myelopathy, holocord enhancing intramedullary lesion C2–T9 (consistent with extensive intramedullary tumor such as ependymoma), intraoperative neuromonitoring shows 60% reduction in MEP amplitude after initial debulking. A >50% drop in MEPs is widely used as a threshold indicating high risk of permanent motor deficit, prompting cessation or backing off the resection to prioritize neurologic safety.\n\nOption B (halt resection, duraplasty, staged approach) aligns with the principle of maximal safe resection guided by neuromonitoring and is the only clearly appropriate immediate surgical decision. A and D advocate continuing despite a major MEP drop, which is unsafe and contrary to intraoperative neuromonitoring standards. C changes the tool but not the decision to continue, ignoring the warning sign. E (en bloc resection of involved segments) is not appropriate for a holocord intramedullary lesion and would be devastating neurologically.\n\nMain medical accuracy issues: Minor—specific 3–6 month interval for staged resection is somewhat dogmatic but not harmful. Minimal fix: Clarify in the explanation that resection is halted immediately upon significant MEP decline and that any further resection is reconsidered only after neurologic and radiologic reassessment.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-010", "question": "A 35-year-old woman is diagnosed with WNT-activated medulloblastoma after gross total resection. Molecular profiling shows CTNNB1 mutation without TP53 alteration. What is the recommended craniospinal irradiation dose and chemotherapy approach?", "options": ["A) 36 Gy craniospinal with posterior fossa boost to 54 Gy plus adjuvant temozolomide", "B) 23.4 Gy craniospinal with boost to 54 Gy, no chemotherapy", "C) 30.6 Gy craniospinal with boost to 55.8 Gy plus concurrent vincristine", "D) 18 Gy craniospinal with boost to 50.4 Gy plus high-dose chemotherapy with stem cell rescue", "E) 36 Gy craniospinal with boost to 55.8 Gy plus cisplatin-based chemotherapy"], "answer": "B", "answer_index": 1, "explanation": "WNT-activated medulloblastoma in adults has >95% 5-year survival, allowing significant craniospinal dose de-escalation to 23.4 Gy with posterior fossa boost to 54 Gy while omitting chemotherapy, reducing neurocognitive and endocrine toxicity. This protocol is supported by COG ACNS1422 and SJMB12 trials. Standard doses cause unnecessary toxicity, and chemotherapy adds no survival benefit in this molecular subgroup.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: N (no answer defensible)\\nVerdict on keyed answer: Not uniquely determinable / key appears incorrect\\nKey stem clues: Adult (35-year-old) with WNT-activated medulloblastoma, gross total resection, CTNNB1 mutation, TP53 wild type. Question asks specifically for *recommended* craniospinal irradiation dose and chemotherapy approach in this setting.\\nMain logical issues: The explanation cites pediatric-focused de-escalation protocols (COG ACNS1422, SJMB12) and asserts omission of chemotherapy for WNT tumors, but these data and practices are not established standards for adults. In adults, standard-risk medulloblastoma generally receives ~35 Gy CSI plus boost with cisplatin-based chemotherapy; WNT biology does not yet routinely justify omission of chemotherapy or such low-dose CSI in adult guidelines. Thus option B (23.4 Gy CSI, no chemotherapy) is not well supported; none of the options clearly reflects current adult-standard WNT-driven risk-adapted care, making no choice clearly defensible as best.\\nMain medical accuracy issues: Overgeneralization of pediatric WNT risk-adaptation to adults; statement that chemotherapy adds no survival benefit in this subgroup in adults is not established.\\nMinimal fix: Specify pediatric patient (e.g., “8-year-old”) and frame question around pediatric WNT medulloblastoma using trials that support 23.4 Gy CSI with no chemotherapy, or adjust options/key to reflect adult-standard therapy if the patient remains 35 years old.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"N\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: N (no answer defensible)\nVerdict on keyed answer: Not uniquely determinable / key appears incorrect\nKey stem clues: Adult (35-year-old) with WNT-activated medulloblastoma, gross total resection, CTNNB1 mutation, TP53 wild type. Question asks specifically for *recommended* craniospinal irradiation dose and chemotherapy approach in this setting.\nMain logical issues: The explanation cites pediatric-focused de-escalation protocols (COG ACNS1422, SJMB12) and asserts omission of chemotherapy for WNT tumors, but these data and practices are not established standards for adults. In adults, standard-risk medulloblastoma generally receives ~35 Gy CSI plus boost with cisplatin-based chemotherapy; WNT biology does not yet routinely justify omission of chemotherapy or such low-dose CSI in adult guidelines. Thus option B (23.4 Gy CSI, no chemotherapy) is not well supported; none of the options clearly reflects current adult-standard WNT-driven risk-adapted care, making no choice clearly defensible as best.\nMain medical accuracy issues: Overgeneralization of pediatric WNT risk-adaptation to adults; statement that chemotherapy adds no survival benefit in this subgroup in adults is not established.\nMinimal fix: Specify pediatric patient (e.g., “8-year-old”) and frame question around pediatric WNT medulloblastoma using trials that support 23.4 Gy CSI with no chemotherapy, or adjust options/key to reflect adult-standard therapy if the patient remains 35 years old.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "N", "verdict": "FAIL", "fail_reason": "N"}, "judge_verdict": "FAIL", "judge_fail_reason": "N", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-011", "question": "A 58-year-old man with mid-rectal cancer (cT3N1M0) has enlarged right obturator lymph node (8 mm) on staging MRI. The primary tumor is 5 cm from the anal verge. What is the optimal treatment sequence?", "options": ["A) Long-course chemoradiation (50.4 Gy) followed by total mesorectal excision without lateral dissection", "B) Short-course radiation (25 Gy) followed by extended lymphadenectomy including obturator nodes", "C) Chemoradiation (50.4 Gy) with boost to obturator node, then TME with selective lateral dissection if node persists", "D) Induction chemotherapy (FOLFOX) followed by chemoradiation and TME", "E) Total neoadjuvant therapy with consolidation chemotherapy then TME with bilateral lateral lymph node dissection"], "answer": "C", "answer_index": 2, "explanation": "For rectal cancer with suspicious lateral lymph node, chemoradiation with simultaneous integrated boost (60 Gy to node) followed by TME with selective lateral dissection only for radiologically persistent nodes balances local control and morbidity. Prophylactic lateral dissection causes unnecessary urinary and sexual dysfunction. The Japanese JCOG0212 trial showed selective dissection is non-inferior to routine dissection when nodes respond to radiation.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: cT3N1M0 mid-rectal cancer (5 cm from anal verge) with an enlarged (8 mm) right obturator lymph node on MRI. This indicates a clinically suspicious lateral pelvic node in a locally advanced low/mid-rectal tumor. Contemporary management in many guideline-based, total-neoadjuvant-therapy–oriented Western protocols emphasizes neoadjuvant chemoradiation, often with boost to suspicious lateral nodes, followed by TME with *selective* lateral lymph node dissection only if nodes remain radiologically suspicious after neoadjuvant therapy.\\nOption C explicitly describes chemoradiation to 50.4 Gy with boost to the obturator node and TME with selective lateral dissection if the node persists, matching the described rationale and standard practice aimed at minimizing unnecessary morbidity from routine prophylactic lateral dissections. Option A omits addressing the suspicious lateral node; B and E advocate routine/extended dissection despite potential response; D omits specific lateral node–directed strategy. Thus, a single best answer exists and matches the key.\\nMain medical issue: minor citation nuance (JCOG data are about prophylactic dissection in low rectal cancer) but teaching point is consistent. Minimal fix: Clarify guideline context (e.g., “according to contemporary Western practice”) or adjust trial citation, but item is already functionally sound.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: cT3N1M0 mid-rectal cancer (5 cm from anal verge) with an enlarged (8 mm) right obturator lymph node on MRI. This indicates a clinically suspicious lateral pelvic node in a locally advanced low/mid-rectal tumor. Contemporary management in many guideline-based, total-neoadjuvant-therapy–oriented Western protocols emphasizes neoadjuvant chemoradiation, often with boost to suspicious lateral nodes, followed by TME with *selective* lateral lymph node dissection only if nodes remain radiologically suspicious after neoadjuvant therapy.\nOption C explicitly describes chemoradiation to 50.4 Gy with boost to the obturator node and TME with selective lateral dissection if the node persists, matching the described rationale and standard practice aimed at minimizing unnecessary morbidity from routine prophylactic lateral dissections. Option A omits addressing the suspicious lateral node; B and E advocate routine/extended dissection despite potential response; D omits specific lateral node–directed strategy. Thus, a single best answer exists and matches the key.\nMain medical issue: minor citation nuance (JCOG data are about prophylactic dissection in low rectal cancer) but teaching point is consistent. Minimal fix: Clarify guideline context (e.g., “according to contemporary Western practice”) or adjust trial citation, but item is already functionally sound.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-012", "question": "A 6-year-old child has a retroperitoneal lymphangioma extending from renal hilum to pelvis, causing refractory chylous ascites requiring weekly paracentesis. Imaging shows a multiloculated cystic mass with thin septations. What is the definitive management?", "options": ["A) Complete surgical excision via retroperitoneal approach", "B) Percutaneous sclerotherapy with doxycycline and ethanol", "C) Laparoscopic fenestration and omental marsupialization", "D) Observation with medium-chain triglyceride diet", "E) Retroperitoneal lymph node dissection with lymphatic ligation"], "answer": "B", "answer_index": 1, "explanation": "Large retroperitoneal lymphangiomas with chylous ascites are best managed with percutaneous sclerotherapy using doxycycline and ethanol, achieving 85% cure rate. The multiloculated nature makes complete surgical excision hazardous due to proximity to renal vessels and pancreas, with 40% recurrence and high morbidity. Sclerotherapy induces fibrosis of lymphatic channels while preserving adjacent structures, and is superior to laparoscopic fenestration for macrocystic lesions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (miskeyed)\\nVerdict on keyed answer: Miskeyed – best supported answer is A, not B.\\n\\nKey stem clues: 6-year-old with large retroperitoneal lymphangioma, multiloculated cystic mass from renal hilum to pelvis, causing *refractory* chylous ascites requiring weekly paracentesis. Question asks for *definitive* management.\\n\\nMedically, standard teaching is that the definitive treatment of symptomatic lymphangiomas is complete surgical excision when feasible; sclerotherapy is an important alternative, particularly for cervicofacial or unresectable lesions, but is generally considered less definitively curative and often requires multiple sessions. For a localized retroperitoneal lesion causing significant symptoms, complete resection is typically preferred as the definitive therapy. Thus option A best matches “definitive management.”\\n\\nOption B (percutaneous sclerotherapy) is reasonable therapy but less clearly “definitive” than complete excision and is guideline-contingent; the provided rationale asserts superiority without widely established consensus. C (fenestration/marsupialization) is palliative, not definitive. D (observation/diet) is inappropriate given refractory ascites. E (LN dissection with ligation) is not standard for lymphangioma.\\n\\nMinimal fix: Either change the stem wording from “definitive management” to “preferred initial treatment in this anatomically high-risk lesion” or change the key to A and adjust the explanation accordingly.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (miskeyed)\nVerdict on keyed answer: Miskeyed – best supported answer is A, not B.\n\nKey stem clues: 6-year-old with large retroperitoneal lymphangioma, multiloculated cystic mass from renal hilum to pelvis, causing *refractory* chylous ascites requiring weekly paracentesis. Question asks for *definitive* management.\n\nMedically, standard teaching is that the definitive treatment of symptomatic lymphangiomas is complete surgical excision when feasible; sclerotherapy is an important alternative, particularly for cervicofacial or unresectable lesions, but is generally considered less definitively curative and often requires multiple sessions. For a localized retroperitoneal lesion causing significant symptoms, complete resection is typically preferred as the definitive therapy. Thus option A best matches “definitive management.”\n\nOption B (percutaneous sclerotherapy) is reasonable therapy but less clearly “definitive” than complete excision and is guideline-contingent; the provided rationale asserts superiority without widely established consensus. C (fenestration/marsupialization) is palliative, not definitive. D (observation/diet) is inappropriate given refractory ascites. E (LN dissection with ligation) is not standard for lymphangioma.\n\nMinimal fix: Either change the stem wording from “definitive management” to “preferred initial treatment in this anatomically high-risk lesion” or change the key to A and adjust the explanation accordingly.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-013", "question": "A 67-year-old man has ocular surface squamous neoplasia involving 5 clock hours of limbus with anterior segment OCT showing 1.2 mm depth of invasion into peripheral cornea. There is no scleral invasion. What is the management?", "options": ["A) Enucleation with orbital implant", "B) Exenteration with adjuvant radiation therapy", "C) Globe-sparing tumor excision with lamellar keratoplasty and adjuvant plaque brachytherapy", "D) Topical interferon alpha-2b for 6 months", "E) Cryotherapy to tumor base with amniotic membrane transplantation"], "answer": "C", "answer_index": 2, "explanation": "Ocular surface squamous neoplasia with intraocular invasion <2 mm depth can be managed with globe-sparing lamellar keratoplasty to clear margins followed by adjuvant strontium-90 plaque brachytherapy (30 Gy to base). This achieves 90% local control while preserving vision. Enucleation is reserved for scleral invasion or recurrence. Topical therapy cannot penetrate intraocular extension, and cryotherapy alone is insufficient for invasive disease.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 67-year-old man; ocular surface squamous neoplasia; 5 clock hours of limbus involved; anterior segment OCT shows 1.2 mm depth of invasion into peripheral cornea; no scleral invasion. These findings describe invasive OSSN with limited intraocular extension (<2 mm) but without scleral involvement.\\nOption C (globe-sparing tumor excision with lamellar keratoplasty and adjuvant plaque brachytherapy) matches contemporary management for invasive OSSN with <2 mm intraocular invasion, aiming for clear margins plus adjuvant radiotherapy to improve local control while preserving the globe.\\nOptions A and B (enucleation or exenteration) are too aggressive in the absence of scleral/orbital invasion or recurrence. Option D (topical interferon) is inadequate for established intraocular extension because topical agents do not treat invasive disease reliably. Option E (cryotherapy with AMT) is appropriate for superficial conjunctival–corneal OSSN, not invasive lesions with 1.2 mm depth.\\nThere is no internal contradiction, and the stem provides sufficient detail (depth, absence of scleral invasion) to uniquely favor option C.\\nMinimal fix: Explicitly state “intraocular extension into peripheral corneal stroma measuring 1.2 mm” to emphasize invasiveness and align with the explanation wording.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 67-year-old man; ocular surface squamous neoplasia; 5 clock hours of limbus involved; anterior segment OCT shows 1.2 mm depth of invasion into peripheral cornea; no scleral invasion. These findings describe invasive OSSN with limited intraocular extension (<2 mm) but without scleral involvement.\nOption C (globe-sparing tumor excision with lamellar keratoplasty and adjuvant plaque brachytherapy) matches contemporary management for invasive OSSN with <2 mm intraocular invasion, aiming for clear margins plus adjuvant radiotherapy to improve local control while preserving the globe.\nOptions A and B (enucleation or exenteration) are too aggressive in the absence of scleral/orbital invasion or recurrence. Option D (topical interferon) is inadequate for established intraocular extension because topical agents do not treat invasive disease reliably. Option E (cryotherapy with AMT) is appropriate for superficial conjunctival–corneal OSSN, not invasive lesions with 1.2 mm depth.\nThere is no internal contradiction, and the stem provides sufficient detail (depth, absence of scleral invasion) to uniquely favor option C.\nMinimal fix: Explicitly state “intraocular extension into peripheral corneal stroma measuring 1.2 mm” to emphasize invasiveness and align with the explanation wording.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-014", "question": "A 78-year-old woman falls and sustains a four-part proximal humerus fracture with head-split pattern and 2 cm medial calcar comminution. The greater tuberosity is fractured but not displaced. What is the optimal implant selection?", "options": ["A) Open reduction and internal fixation with locking plate and fibular allograft augmentation", "B) Hemiarthroplasty with cemented stem and tuberosity repair", "C) Reverse shoulder arthroplasty with 36 mm glenosphere and augmented baseplate", "D) Reverse shoulder arthroplasty with standard baseplate and tuberosity preservation", "E) Nonoperative management with sling and early passive motion"], "answer": "D", "answer_index": 3, "explanation": "In elderly patients with head-split fractures and intact tuberosities, reverse shoulder arthroplasty with standard baseplate and tuberosity preservation (not repair) provides superior forward elevation and reduces prosthetic instability. Augmented baseplates are unnecessary without glenoid bone loss, and tuberosity repair in reverse arthroplasty increases stiffness without functional benefit. ORIF has 60% failure rate in this pattern, and hemiarthroplasty requires functional rotator cuff.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 78-year-old (elderly), four-part proximal humerus fracture, head-split pattern, 2 cm medial calcar comminution (severe metaphyseal compromise), greater tuberosity fractured but not displaced, question asks for optimal implant selection. In this age group and fracture pattern, ORIF has high failure/AVN and requires good bone stock; hemiarthroplasty outcomes depend on tuberosity healing and rotator cuff. Reverse shoulder arthroplasty (RSA) is current standard for complex 3- and 4-part/proximal head-split fractures in elderly with poor bone quality.\\n\\nChoice D (RSA with standard baseplate and tuberosity preservation) is best: RSA addresses cuff deficiency risk, is less dependent on tuberosity healing for elevation, and standard baseplate is appropriate as no glenoid bone loss is described. A is inferior given high failure in this pattern. B is less favored than RSA in modern practice for this scenario. C adds an augmented baseplate without indication. E is inappropriate for displaced four-part head-split fracture in an elderly patient.\\n\\nMain medical/logical issues: Minor nuance about “preservation vs repair” of tuberosity in RSA, but it does not change best-answer ranking.\\n\\nMinimal fix: Explicitly state absent glenoid bone loss and patient is an independent community-dweller to reinforce RSA choice and baseplate selection.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 78-year-old (elderly), four-part proximal humerus fracture, head-split pattern, 2 cm medial calcar comminution (severe metaphyseal compromise), greater tuberosity fractured but not displaced, question asks for optimal implant selection. In this age group and fracture pattern, ORIF has high failure/AVN and requires good bone stock; hemiarthroplasty outcomes depend on tuberosity healing and rotator cuff. Reverse shoulder arthroplasty (RSA) is current standard for complex 3- and 4-part/proximal head-split fractures in elderly with poor bone quality.\n\nChoice D (RSA with standard baseplate and tuberosity preservation) is best: RSA addresses cuff deficiency risk, is less dependent on tuberosity healing for elevation, and standard baseplate is appropriate as no glenoid bone loss is described. A is inferior given high failure in this pattern. B is less favored than RSA in modern practice for this scenario. C adds an augmented baseplate without indication. E is inappropriate for displaced four-part head-split fracture in an elderly patient.\n\nMain medical/logical issues: Minor nuance about “preservation vs repair” of tuberosity in RSA, but it does not change best-answer ranking.\n\nMinimal fix: Explicitly state absent glenoid bone loss and patient is an independent community-dweller to reinforce RSA choice and baseplate selection.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-015", "question": "A 42-year-old woman has a 3 cm proximal urethral diverticulum containing multiple calculi on MRI. She has recurrent urinary tract infections and post-void dribbling. What is the optimal surgical approach?", "options": ["A) Transvaginal diverticulectomy with urethral reconstruction and stone extraction", "B) Endoscopic unroofing with laser lithotripsy of calculi", "C) Transvaginal marsupialization with stone extraction and layered closure", "D) Urethral dilation and transurethral stone extraction", "E) Laparoscopic diverticulectomy with robotic assistance"], "answer": "C", "answer_index": 2, "explanation": "Proximal urethral diverticulum with calculi is best managed via transvaginal marsupialization with complete stone extraction and multilayered closure (urethra, periurethral fascia, vaginal wall). This preserves urethral length and continence while eliminating the stone-bearing cavity. Formal diverticulectomy risks urethral stricture and incontinence. Endoscopic unroofing is inadequate for proximal lesions and leaves stone fragments. Laparoscopic approach offers no advantage for this extraperitoneal pathology.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed)\\nVerdict on keyed answer: Miskeyed – option A is the better, standard answer.\\n\\nKey stem clues: 42-year-old woman, 3 cm proximal urethral diverticulum, contains multiple calculi, recurrent UTIs, post-void dribbling. The question asks for the optimal surgical approach. For female urethral diverticulum, particularly a sizable (3 cm) diverticulum with stones, standard management is transvaginal diverticulectomy with multilayer urethral reconstruction and complete stone removal. This is exactly described in option A.\\n\\nMain logical/medical issues: The explanation mistakenly calls transvaginal marsupialization with layered closure (C) preferred and portrays formal diverticulectomy (A) as higher risk for stricture/incontinence. In mainstream urologic/urogynecologic practice and board-style teaching, marsupialization is not preferred for a proximal diverticulum with calculi because it creates a permanent pouch/fistula into the vagina and is used rarely (e.g., distal, small, or poor surgical candidates). Endoscopic unroofing, urethral dilation, and laparoscopic/robotic approaches are all correctly deprioritized.\\n\\nMinimal fix: Change the keyed answer to A and revise the explanation to state that standard treatment is transvaginal diverticulectomy with meticulous multilayer closure and stone extraction; describe marsupialization as nonstandard/second-line for select distal cases.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed)\nVerdict on keyed answer: Miskeyed – option A is the better, standard answer.\n\nKey stem clues: 42-year-old woman, 3 cm proximal urethral diverticulum, contains multiple calculi, recurrent UTIs, post-void dribbling. The question asks for the optimal surgical approach. For female urethral diverticulum, particularly a sizable (3 cm) diverticulum with stones, standard management is transvaginal diverticulectomy with multilayer urethral reconstruction and complete stone removal. This is exactly described in option A.\n\nMain logical/medical issues: The explanation mistakenly calls transvaginal marsupialization with layered closure (C) preferred and portrays formal diverticulectomy (A) as higher risk for stricture/incontinence. In mainstream urologic/urogynecologic practice and board-style teaching, marsupialization is not preferred for a proximal diverticulum with calculi because it creates a permanent pouch/fistula into the vagina and is used rarely (e.g., distal, small, or poor surgical candidates). Endoscopic unroofing, urethral dilation, and laparoscopic/robotic approaches are all correctly deprioritized.\n\nMinimal fix: Change the keyed answer to A and revise the explanation to state that standard treatment is transvaginal diverticulectomy with meticulous multilayer closure and stone extraction; describe marsupialization as nonstandard/second-line for select distal cases.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-016", "question": "A 55-year-old man has left vocal fold paralysis 6 months after thyroidectomy, with persistent aspiration and breathy voice. EMG shows absent motor unit potentials. What is the optimal injection laryngoplasty material?", "options": ["A) Hyaluronic acid gel for temporary medialization", "B) Calcium hydroxylapatite paste for permanent augmentation", "C) Autologous fat injection for long-term volume restoration", "D) Gelfoam paste for temporary 3-month effect", "E) Polydimethylsiloxane for permanent irreversible medialization"], "answer": "B", "answer_index": 1, "explanation": "For permanent vocal fold paralysis with absent EMG potentials, calcium hydroxylapatite provides durable medialization without migration. Its high viscosity prevents particle dispersion, and it integrates into tissue without foreign body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat has unpredictable resorption (50-80% at 1 year), and polydimethylsiloxane risks granuloma formation and airway compromise if overinjected.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 55-year-old man, 6 months after thyroidectomy; left vocal fold paralysis with persistent aspiration and breathy voice; EMG shows absent motor unit potentials (indicating poor/absent chance of recovery); question explicitly asks for “optimal injection laryngoplasty material.” In a patient with established permanent unilateral vocal fold paralysis, a durable injectable with good safety and limited migration is preferred. Calcium hydroxylapatite is widely used for medium- to long-term augmentation (often several years) and is considered the standard durable injectable in this context.\\nAlternatives: Hyaluronic acid and Gelfoam are clearly temporary and inappropriate for a case that appears permanent. Autologous fat has well-known unpredictable resorption and variable long-term results, so is less optimal as the single best answer. Polydimethylsiloxane has concerns of granuloma and airway compromise, making it less favored.\\nMain medical accuracy issues: Minor oversimplification calling CaHA “permanent,” but consistent with durable clinical behavior.\\nMinimal fix: Rephrase option B to “Calcium hydroxylapatite paste for long-lasting (multi-year) augmentation” instead of “permanent,” to better match current understanding and terminology.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 55-year-old man, 6 months after thyroidectomy; left vocal fold paralysis with persistent aspiration and breathy voice; EMG shows absent motor unit potentials (indicating poor/absent chance of recovery); question explicitly asks for “optimal injection laryngoplasty material.” In a patient with established permanent unilateral vocal fold paralysis, a durable injectable with good safety and limited migration is preferred. Calcium hydroxylapatite is widely used for medium- to long-term augmentation (often several years) and is considered the standard durable injectable in this context.\nAlternatives: Hyaluronic acid and Gelfoam are clearly temporary and inappropriate for a case that appears permanent. Autologous fat has well-known unpredictable resorption and variable long-term results, so is less optimal as the single best answer. Polydimethylsiloxane has concerns of granuloma and airway compromise, making it less favored.\nMain medical accuracy issues: Minor oversimplification calling CaHA “permanent,” but consistent with durable clinical behavior.\nMinimal fix: Rephrase option B to “Calcium hydroxylapatite paste for long-lasting (multi-year) augmentation” instead of “permanent,” to better match current understanding and terminology.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-017", "question": "A 45-year-old man with T6 complete spinal cord injury has a stage 4 sacral pressure ulcer with positive probe-to-bone test and MRI showing marrow edema limited to cortex. He has been on antibiotics for 4 weeks with minimal improvement. What is definitive management?", "options": ["A) Continue suppressive antibiotics indefinitely with wound care", "B) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap", "C) Radical debridement with partial sacrectomy and omental flap", "D) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks", "E) Osteomyelitis excision with free latissimus dorsi muscle flap"], "answer": "B", "answer_index": 1, "explanation": "Stage 4 sacral ulcer with cortical osteomyelitis requires surgical debridement with burr drilling of exposed bone to bleeding cortex, followed by VAC therapy to prepare granulation tissue, then gluteal myocutaneous flap coverage. This achieves 85% healing rates. Partial sacrectomy is reserved for medullary involvement. Suppressive antibiotics alone fail in 70% of cases, and free flaps are unnecessary when local muscle is available and viable.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: T6 complete SCI (insensate area, high risk for recurrent pressure ulcers), stage 4 sacral ulcer, positive probe-to-bone, MRI with marrow edema limited to cortex (cortical osteomyelitis only), 4 weeks of antibiotics with minimal improvement. These collectively indicate chronic sacral pressure-ulcer–associated cortical osteomyelitis requiring definitive local surgical management with durable soft-tissue coverage. Option B—surgical debridement to bone with burr drilling to healthy bleeding cortex, VAC to optimize the wound bed, then local gluteal myocutaneous flap—is standard definitive treatment for cortical involvement when local tissue is available. \\nAlternatives: A (indefinite suppressive antibiotics) is non-definitive and has high failure/recurrence; D (biopsy + 12 weeks IV antibiotics) similarly under-treats chronic pressure-ulcer–associated osteomyelitis without debridement; C (partial sacrectomy) is excessive for disease limited to cortex; E (free latissimus flap) is unnecessary when local gluteal muscle is viable.\\nMain medical issue(s): Content aligns with accepted reconstructive and infectious-disease management of pressure-ulcer–associated sacral osteomyelitis.\\nMinimal fix: Clarify in stem that gluteal musculature and local soft tissues are viable to solidify B as uniquely best versus free flap options.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: T6 complete SCI (insensate area, high risk for recurrent pressure ulcers), stage 4 sacral ulcer, positive probe-to-bone, MRI with marrow edema limited to cortex (cortical osteomyelitis only), 4 weeks of antibiotics with minimal improvement. These collectively indicate chronic sacral pressure-ulcer–associated cortical osteomyelitis requiring definitive local surgical management with durable soft-tissue coverage. Option B—surgical debridement to bone with burr drilling to healthy bleeding cortex, VAC to optimize the wound bed, then local gluteal myocutaneous flap—is standard definitive treatment for cortical involvement when local tissue is available. \nAlternatives: A (indefinite suppressive antibiotics) is non-definitive and has high failure/recurrence; D (biopsy + 12 weeks IV antibiotics) similarly under-treats chronic pressure-ulcer–associated osteomyelitis without debridement; C (partial sacrectomy) is excessive for disease limited to cortex; E (free latissimus flap) is unnecessary when local gluteal muscle is viable.\nMain medical issue(s): Content aligns with accepted reconstructive and infectious-disease management of pressure-ulcer–associated sacral osteomyelitis.\nMinimal fix: Clarify in stem that gluteal musculature and local soft tissues are viable to solidify B as uniquely best versus free flap options.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-018", "question": "A 35-year-old man sustains deep partial-thickness burns to both upper eyelids with early cicatricial ectropion and 3 mm scleral show. The tarsal plate is intact but contracted. What is the optimal reconstruction timing and technique?", "options": ["A) Immediate full-thickness skin graft from supraclavicular fossa with tarsorrhaphy", "B) Delayed reconstruction at 6 months with split-thickness skin graft and Frost suture", "C) Immediate Mustarde cheek advancement flap with cartilage graft", "D) Delayed full-thickness skin graft from postauricular area with tarsal release", "E) Immediate temporoparietal fascia flap with skin graft"], "answer": "D", "answer_index": 3, "explanation": "For post-burn eyelid ectropion with tarsal contracture, delayed reconstruction at 6-12 months with full-thickness postauricular skin graft after complete tarsal release provides optimal color match and prevents retraction. Immediate grafting fails due to ongoing inflammation and inadequate recipient bed vascularity. Mustarde flaps are excessive for isolated eyelid involvement, and temporoparietal fascia is reserved for total eyelid loss. Postauricular skin has thinner dermis than supraclavicular, better matching eyelid architecture.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: 35-year-old man, deep partial-thickness thermal burns to both upper lids, early cicatricial ectropion with 3 mm scleral show, tarsal plate intact but contracted. Question explicitly asks for optimal reconstruction timing and technique.\\n\\nFor post-burn cicatricial ectropion with tarsal contracture, standard oculoplastic/burn practice favors delayed reconstruction (after scar maturation, ~6–12 months) with full-thickness skin graft from a thin, well-matched donor site (often postauricular) after complete release of scar contracture. This minimizes graft contraction and improves color/texture match. Thus option D (“Delayed full-thickness skin graft from postauricular area with tarsal release”) matches best.\\n\\nOption A uses immediate FTSG during acute inflammatory phase and a supraclavicular donor (thicker dermis, worse match). B uses split-thickness graft (more secondary contraction) and relatively early timing. C (Mustarde cheek flap, cartilage graft) and E (TPF flap) are excessive for intact but contracted tarsus and isolated eyelid skin deficiency.\\n\\nNo major internal contradictions or underspecification are present; one clearly superior option exists and matches the key. Medical logic and reconstructive principles are current and accurate.\\n\\nMinimal fix: Specify “after scar maturation (≈6–12 months)” in the question stem or option D to align exactly with the explanation’s timing nuance.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: 35-year-old man, deep partial-thickness thermal burns to both upper lids, early cicatricial ectropion with 3 mm scleral show, tarsal plate intact but contracted. Question explicitly asks for optimal reconstruction timing and technique.\n\nFor post-burn cicatricial ectropion with tarsal contracture, standard oculoplastic/burn practice favors delayed reconstruction (after scar maturation, ~6–12 months) with full-thickness skin graft from a thin, well-matched donor site (often postauricular) after complete release of scar contracture. This minimizes graft contraction and improves color/texture match. Thus option D (“Delayed full-thickness skin graft from postauricular area with tarsal release”) matches best.\n\nOption A uses immediate FTSG during acute inflammatory phase and a supraclavicular donor (thicker dermis, worse match). B uses split-thickness graft (more secondary contraction) and relatively early timing. C (Mustarde cheek flap, cartilage graft) and E (TPF flap) are excessive for intact but contracted tarsus and isolated eyelid skin deficiency.\n\nNo major internal contradictions or underspecification are present; one clearly superior option exists and matches the key. Medical logic and reconstructive principles are current and accurate.\n\nMinimal fix: Specify “after scar maturation (≈6–12 months)” in the question stem or option D to align exactly with the explanation’s timing nuance.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-019", "question": "A 12-year-old girl with Chiari I malformation and holocord syringomyelia undergoes posterior fossa decompression. Intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. What is the next step?", "options": ["A) Perform duraplasty with bovine pericardial graft and tonsillectomy", "B) Perform duraplasty with autologous pericranial graft without tonsillectomy", "C) Extend bone decompression to C2 without dural opening", "D) Perform tonsillectomy only without duraplasty", "E) Place syringosubarachnoid shunt"], "answer": "B", "answer_index": 1, "explanation": "When intraoperative ultrasound shows persistent syrinx after bone decompression, duraplasty with autologous pericranial graft restores normal CSF flow dynamics without tonsillectomy. Autologous graft reduces pseudomeningocele risk compared to allograft. Tonsillectomy adds morbidity without additional syrinx resolution when duraplasty alone achieves flow restoration. Syringosubarachnoid shunt is reserved for failed decompression, and extending bone removal is ineffective without addressing dural restriction.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 12‑year‑old with Chiari I and holocord syrinx; has already undergone posterior fossa bony decompression; intraoperative ultrasound after bone removal shows persistent syrinx with persistent tonsillar pulsation. This implies inadequate restoration of CSF flow at the foramen magnum due to dural/arachnoid restriction rather than bony constraint.\\nThe most appropriate next step is dural expansion with an autologous pericranial graft without tonsillar resection (option B), which is standard contemporary practice to improve CSF flow while minimizing graft-related complications and avoiding added morbidity of tonsillar resection.\\nOption A (bovine graft + tonsillectomy) introduces nonautologous material (higher pseudomeningocele/CSF leak) and unnecessary tonsillar resection. C (extend bone to C2 without opening dura) fails to address the dural bottleneck. D (tonsillectomy alone) does not expand the cisterna magna or dural space. E (syringosubarachnoid shunt) is a rescue procedure reserved for failed decompressions.\\nNo major internal contradictions or underspecification; for a board-style item, the discriminating teaching point (autologous duraplasty without tonsillectomy as next step) is clear.\\nMinimal fix: Explicitly state “after suboccipital craniectomy and C1 laminectomy” to clarify extent of bony decompression already performed, but this is not essential for answer discrimination.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 12‑year‑old with Chiari I and holocord syrinx; has already undergone posterior fossa bony decompression; intraoperative ultrasound after bone removal shows persistent syrinx with persistent tonsillar pulsation. This implies inadequate restoration of CSF flow at the foramen magnum due to dural/arachnoid restriction rather than bony constraint.\nThe most appropriate next step is dural expansion with an autologous pericranial graft without tonsillar resection (option B), which is standard contemporary practice to improve CSF flow while minimizing graft-related complications and avoiding added morbidity of tonsillar resection.\nOption A (bovine graft + tonsillectomy) introduces nonautologous material (higher pseudomeningocele/CSF leak) and unnecessary tonsillar resection. C (extend bone to C2 without opening dura) fails to address the dural bottleneck. D (tonsillectomy alone) does not expand the cisterna magna or dural space. E (syringosubarachnoid shunt) is a rescue procedure reserved for failed decompressions.\nNo major internal contradictions or underspecification; for a board-style item, the discriminating teaching point (autologous duraplasty without tonsillectomy as next step) is clear.\nMinimal fix: Explicitly state “after suboccipital craniectomy and C1 laminectomy” to clarify extent of bony decompression already performed, but this is not essential for answer discrimination.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-020", "question": "A 62-year-old man with T2N0M0 glottic carcinoma involving the anterior commissure is scheduled for definitive radiation therapy. He has good performance status and no comorbidities. What is the optimal fractionation scheme to maximize local control?", "options": ["A) 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin", "B) 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab", "C) 72 Gy in 42 fractions using concomitant boost over 6 weeks", "D) 60 Gy in 30 fractions over 6 weeks with hyperfractionation", "E) 50 Gy in 20 fractions over 4 weeks with hypofractionation"], "answer": "C", "answer_index": 2, "explanation": "For T2 glottic cancer with anterior commissure involvement, altered fractionation with concomitant boost (72 Gy/42 fractions/6 weeks) improves 5-year local control to 85% versus 70% with standard fractionation, without increasing late toxicity. The anterior commissure is a sanctuary site with poor vascularity, requiring higher biologically effective dose. Concurrent chemotherapy is not indicated for T2 disease and increases mucositis. Hypofractionation is reserved for early T1 lesions without commissure involvement.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: T2N0M0 glottic carcinoma, anterior commissure involvement, definitive radiation (not chemoradiation), goal is maximizing local control in a fit 62-year-old. For T2 glottic, especially with anterior commissure (poorer control, sanctuary site), many contemporary series and guideline-based practice support altered fractionation/accelerated regimens to improve local control without routine concurrent chemotherapy. Concomitant boost to 72 Gy in 42 fractions over 6 weeks (Option C) matches that principle and the provided rationale.\\nOption review: A and B add concurrent systemic therapy (cisplatin or cetuximab), which is generally reserved for T3/T4 or node-positive laryngeal cancers, not T2N0; they increase acute toxicity without clear benefit here. D (60 Gy/30 fractions with hyperfractionation) is ambiguous: true hyperfractionation typically uses more total dose (e.g., ~81.6 Gy) with twice-daily fractions; 60 Gy/30 is just conventional once-daily. E (50 Gy/20) is hypofractionated and underdoses a T2 lesion.\\nMain medical/logical issue: Minor terminology/dose realism for option D and somewhat assertive claim about no increased late toxicity but overall teaching is aligned with standard.\\nMinimal fix: Rephrase D as a realistic hyperfractionated schedule (e.g., 81.6 Gy in 68 BID fractions over 7 weeks) to avoid confusion and better contrast with C.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: T2N0M0 glottic carcinoma, anterior commissure involvement, definitive radiation (not chemoradiation), goal is maximizing local control in a fit 62-year-old. For T2 glottic, especially with anterior commissure (poorer control, sanctuary site), many contemporary series and guideline-based practice support altered fractionation/accelerated regimens to improve local control without routine concurrent chemotherapy. Concomitant boost to 72 Gy in 42 fractions over 6 weeks (Option C) matches that principle and the provided rationale.\nOption review: A and B add concurrent systemic therapy (cisplatin or cetuximab), which is generally reserved for T3/T4 or node-positive laryngeal cancers, not T2N0; they increase acute toxicity without clear benefit here. D (60 Gy/30 fractions with hyperfractionation) is ambiguous: true hyperfractionation typically uses more total dose (e.g., ~81.6 Gy) with twice-daily fractions; 60 Gy/30 is just conventional once-daily. E (50 Gy/20) is hypofractionated and underdoses a T2 lesion.\nMain medical/logical issue: Minor terminology/dose realism for option D and somewhat assertive claim about no increased late toxicity but overall teaching is aligned with standard.\nMinimal fix: Rephrase D as a realistic hyperfractionated schedule (e.g., 81.6 Gy in 68 BID fractions over 7 weeks) to avoid confusion and better contrast with C.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}]